Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients (Q73928161)
Jump to navigation
Jump to search
scientific article published on 01 March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients |
scientific article published on 01 March 2001 |
Statements
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients (English)
E Abraham
P F Laterre
J Garbino
S Pingleton
T Butler
T Dugernier
B Margolis
K Kudsk
W Zimmerli
P Anderson
M Reynaert
W Lesslauer
S Passe
P Cooper
A Burdeska
M Modi
A Leighton
M Salgo
P Van der Auwera
Lenercept Study Group